Just The News on MSN
After years of requests, feds still won't explain plunge in people taking COVID vax second dose
Administration has repeatedly irked presumed allies on COVID vaccine policy, from its silence on reported 32 million ...
CEO, Dr Eric Leire, talked with Proactive about the company's upcoming presentation at the Animal Longevity Summit in Toronto ...
To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.
MarketBeat on MSN
MarketBeat Week in Review – 06/29 - 07/03
Key Points Interested in AirJoule Technologies Corporation? Here are five stocks we like better. Markets ended a shortened ...
A new kind of flu vaccine is moving a step closer to the U.S. market.
Jeff Coller, a pioneering RNA biologist, has spent the past year vehemently advocating for the lifesaving promise of research ...
You can listen to more articles from The Conversation, narrated by Noa, here. Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
CEO Amy Walker joined Proactive's Stephen Gunnion to discuss the company's synthetic DNA platform, growing commercial ...
Moderna has unveiled its first in vivo CAR-T program. Building on other groups’ ex vivo CAR-T data, the company plans to start clinical development of an off-the-shelf autoimmune disease prospect, ...
A study in zebrafish shows that neuronal microexons regulate brain activity by modulating cAMP signaling. Loss of these ...
The Office of Management and Budget has proposed rule changes to insert a political review step into the scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results